Comparison of serotonin agonists in combination with phentermine for treatment of obesity

被引：0
|
作者：
Dhurandhar, NV [1 ]
Atkinson, RL [1 ]
机构：
[1] UNIV WISCONSIN,MADISON,WI 53706
来源：
FASEB JOURNAL | 1996年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
下载
收藏
页码：3231 / 3231
页数：1
相关论文
共 50 条
  • [31] SEROTONIN PARTIAL AGONISTS IN THE TREATMENT OF ANXIETY AND DEPRESSION - INTRODUCTION
    DUDLEY, RG
    JOURNAL OF CLINICAL PSYCHIATRY, 1990, 51 : 30 - 30
  • [32] Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
    Lewis, Kristina H.
    Gudzune, Kimberly A.
    Ard, Jamy D.
    CURRENT OBESITY REPORTS, 2024, 13 (01) : 132 - 140
  • [33] Addiction potential of phentermine prescribed during long-term treatment of obesity
    E J Hendricks
    M Srisurapanont
    S L Schmidt
    M Haggard
    S Souter
    C L Mitchell
    D G De Marco
    M J Hendricks
    Y Istratiy
    F L Greenway
    International Journal of Obesity, 2014, 38 : 292 - 298
  • [34] Addiction potential of phentermine prescribed during long-term treatment of obesity
    Hendricks, E. J.
    Srisurapanont, M.
    Schmidt, S. L.
    Haggard, M.
    Souter, S.
    Mitchell, C. L.
    De Marco, D. G.
    Hendricks, M. J.
    Istratiy, Y.
    Greenway, F. L.
    INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (02) : 292 - 298
  • [35] Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment?
    Kristina H. Lewis
    Kimberly A. Gudzune
    Jamy D. Ard
    Current Obesity Reports, 2024, 13 : 132 - 140
  • [36] Comparison of weight loss, psychological and psychometric characteristics with dexfenfluramine/phentermine and fenfluramine/phentermine treatment in obese humans.
    Heuberger, RA
    Atkinson, RL
    FASEB JOURNAL, 1998, 12 (05): : A865 - A865
  • [37] Leptin agonists as a potential approach to the treatment of obesity
    Lee, DW
    Leinung, MC
    Rozhavskaya-Arena, M
    Grasso, P
    DRUGS OF THE FUTURE, 2001, 26 (09) : 873 - 881
  • [38] β3 receptor agonists for the treatment of obesity.
    Shuker, AJ
    Bell, MG
    Bloomquist, W
    Calligaro, DO
    Cohen, ML
    Crowell, TA
    Cusick, TS
    Droste, CA
    Evrard, DA
    Hahn, PJ
    Heiman, ML
    Jesudason, CD
    Jones, CD
    Kim, G
    Kriauciunas, AV
    Matthews, DP
    McDonald, JH
    Neel, DA
    Palkowitz, AD
    Peters, MK
    Rito, CJ
    Siegel, MG
    Stephens, TW
    Winter, MA
    Dananberg, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1202 - U1202
  • [39] The role of incretin receptor agonists in the treatment of obesity
    Forst, Thomas
    De Block, Christophe
    Del Prato, Stefano
    Armani, Sara
    Frias, Juan
    Lautenbach, Anne
    Ludvik, Bernhard
    Marinez, Marina
    Mathieu, Chantal
    Mueller, Timo D.
    Schnell, Oliver
    DIABETES OBESITY & METABOLISM, 2024,
  • [40] Combination treatment to CONQUER obesity?
    Shah, Krupa
    Villareal, Dennis T.
    LANCET, 2011, 377 (9774): : 1295 - 1297
12345